Suppression of Bcl-xL expression by a novel tumor-specific RNA interference system inhibits proliferation and enhances radiosensitivity in prostatic carcinoma cells
Authors:
- 26 July 2007
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 61 (6) , 943-952
Abstract
Bcl-xL, a novel member of anti-apoptotic Bcl-2 family that play important roles in regulating cell survival and apoptosis, is frequently overexpressed in various kinds of human cancers, including prostatic carcinoma. To explore its possibility as a therapeutic target for prostatic carcinoma, we developed a novel tumor-specific RNA interference system by using survivin promoter and employed it to suppress exogenous reporters (LUC and EGFP) and endogenous gene Bcl-xL expression and analyzed its phenotypes. We found that expression of exogenous reporters (LUC and EGFP) was specifically inhibited in tumor cells but not in normal cells. We also observed that the specific inhibition of Bcl-xL in human prostatic carcinoma cells (PC3) strongly suppressed in vitro cell proliferation and in vivo tumorigenicity. We observed significant apoptosis induction and radiosensitivity enhancement in PC3 cells by the RNA interference-mediated suppression of Bcl-xL expression. All these results indicate that inhibition of Bcl-xL expression can result in potent antitumor activity and radiosensitization in human prostatic carcinoma.Keywords
This publication has 20 references indexed in Scilit:
- Gene silencing in alveolar type II cells using cell-specific promoter in vitro and in vivoNucleic Acids Research, 2004
- MicroRNA genes are transcribed by RNA polymerase IIThe EMBO Journal, 2004
- Unlocking the potential of the human genome with RNA interferenceNature, 2004
- CRE recombinase-inducible RNA interference mediated by lentiviral vectorsProceedings of the National Academy of Sciences, 2004
- Small RNA: can RNA interference be exploited for therapy?The Lancet, 2003
- Short hairpin type of dsRNAs that are controlled by tRNAVal promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cellsNucleic Acids Research, 2003
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- A DNA vector-based RNAi technology to suppress gene expression in mammalian cellsProceedings of the National Academy of Sciences, 2002
- The expression of antiapoptotic proteins Bcl-2, Bcl-XL, and Mcl-1 in benign, dysplastic, and malignant biliary epitheliumJournal of Clinical Pathology, 2001
- Expression and Role of Bcl–Xl in Human Hepatocellular CarcinomasHepatology, 2001